Seres Therapeutics, Inc. · NASDAQ:MCRB
Henn Matthew R sold 77 Seres Therapeutics, Inc. shares (Form 4)
Traded May 15 to May 18, 2026 · Filed May 19, 2026
From May 15 to May 18, 2026, Henn Matthew R (See Remarks) sold 77 Seres Therapeutics, Inc. shares at US$7.53 for US$580 under a trading plan, leaving 7,838 shares. Filed May 19, 2026 (Form 4).
- Sold
- 77 shares
- Price
- US$7.53
- Value
- US$580
- Holding after
- 7,838 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Option exercise | 238 | 7,915 | Direct | |
| May 18, 2026 | Common Stock | Sale | 77 | US$7.53 | 7,838 | Direct |